298 related articles for article (PubMed ID: 23786711)
21. Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.
Chini MG; De Simone R; Bruno I; Riccio R; Dehm F; Weinigel C; Barz D; Werz O; Bifulco G
Eur J Med Chem; 2012 Aug; 54():311-23. PubMed ID: 22683242
[TBL] [Abstract][Full Text] [Related]
22. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
23. Development of dual targeting inhibitors against aggregations of amyloid-β and tau protein.
Fuse S; Matsumura K; Fujita Y; Sugimoto H; Takahashi T
Eur J Med Chem; 2014 Oct; 85():228-34. PubMed ID: 25086914
[TBL] [Abstract][Full Text] [Related]
24. Exploring the 2'-Hydroxy-Chalcone Framework for the Development of Dual Antioxidant and Soybean Lipoxygenase Inhibitory Agents.
Kostopoulou I; Tzani A; Polyzos NI; Karadendrou MA; Kritsi E; Pontiki E; Liargkova T; Hadjipavlou-Litina D; Zoumpoulakis P; Detsi A
Molecules; 2021 May; 26(9):. PubMed ID: 34066803
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
Li RS; Wang XB; Hu XJ; Kong LY
Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
[TBL] [Abstract][Full Text] [Related]
26. Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
Peduto A; Bruno F; Dehm F; Krauth V; de Caprariis P; Weinigel C; Barz D; Massa A; De Rosa M; Werz O; Filosa R
Eur J Med Chem; 2014 Jun; 81():492-8. PubMed ID: 24871899
[TBL] [Abstract][Full Text] [Related]
27. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of 2'-Aminochalcone: A multi-target approach to find drug candidates to treat Alzheimer's disease.
Sakata RP; Antoniolli G; Lancellotti M; Kawano DF; Guimarães Barbosa E; Almeida WP
Bioorg Chem; 2020 Oct; 103():104201. PubMed ID: 32890999
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, in vitro and in silico evaluation of diaryl heptanones as potential 5LOX enzyme inhibitors.
Meka B; Ravada SR; Muthyala MKK; Kurre PN; Golakoti T
Bioorg Chem; 2018 Oct; 80():408-421. PubMed ID: 29986187
[TBL] [Abstract][Full Text] [Related]
30. SAR-study on a new class of imidazo[1,2-a]pyridine-based inhibitors of 5-lipoxygenase.
Hieke M; Rödl CB; Wisniewska JM; la Buscató E; Stark H; Schubert-Zsilavecz M; Steinhilber D; Hofmann B; Proschak E
Bioorg Med Chem Lett; 2012 Mar; 22(5):1969-75. PubMed ID: 22326163
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation.
Panek D; Więckowska A; Wichur T; Bajda M; Godyń J; Jończyk J; Mika K; Janockova J; Soukup O; Knez D; Korabecny J; Gobec S; Malawska B
Eur J Med Chem; 2017 Jan; 125():676-695. PubMed ID: 27721153
[TBL] [Abstract][Full Text] [Related]
32. Benzofuran-chalcone hybrids as potential multifunctional agents against Alzheimer's disease: synthesis and in vivo studies with transgenic Caenorhabditis elegans.
Sashidhara KV; Modukuri RK; Jadiya P; Dodda RP; Kumar M; Sridhar B; Kumar V; Haque R; Siddiqi MI; Nazir A
ChemMedChem; 2014 Dec; 9(12):2671-84. PubMed ID: 25251917
[TBL] [Abstract][Full Text] [Related]
33. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
34. Caulerpenyne and related bis-enol esters are novel-type inhibitors of human 5-lipoxygenase.
Richter P; Schubert G; Schaible AM; Cavas L; Werz O; Pohnert G
ChemMedChem; 2014 Aug; 9(8):1655-9. PubMed ID: 24729578
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of benzoxazole derivatives as 5-lipoxygenase inhibitors.
Song H; Oh SR; Lee HK; Han G; Kim JH; Chang HW; Doh KE; Rhee HK; Choo HY
Bioorg Med Chem; 2010 Nov; 18(21):7580-5. PubMed ID: 20870413
[TBL] [Abstract][Full Text] [Related]
36. Design of multi-target compounds as AChE, BACE1, and amyloid-β(1-42) oligomerization inhibitors: in silico and in vitro studies.
Hernández-Rodríguez M; Correa-Basurto J; Martínez-Ramos F; Padilla-Martínez II; Benítez-Cardoza CG; Mera-Jiménez E; Rosales-Hernández MC
J Alzheimers Dis; 2014; 41(4):1073-85. PubMed ID: 24762947
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and evaluation of 2-piperidone derivatives for the inhibition of β-amyloid aggregation and inflammation mediated neurotoxicity.
Li L; Chen M; Jiang FC
Bioorg Med Chem; 2016 Apr; 24(8):1853-65. PubMed ID: 26972922
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
[TBL] [Abstract][Full Text] [Related]
39. Investigation on the influence of (Z)-3-(2-(3-chlorophenyl)hydrazono)-5,6-dihydroxyindolin-2-one (PT2) on β-amyloid(1-40) aggregation and toxicity.
Catto M; Arnesano F; Palazzo G; De Stradis A; Calò V; Losacco M; Purgatorio R; Campagna F
Arch Biochem Biophys; 2014 Oct; 560():73-82. PubMed ID: 25051344
[TBL] [Abstract][Full Text] [Related]
40. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
